1. Fleckenstein A: Specific inhibitors and promoters of calcium action in the excitation-con-tractioncoupling of heart muscle and their role in the prevention or production of myocardial lesions. In: Calcium and the Heart, (Harris P, Opie L eds.), PP 135–188, Academic Press, London-New York, 1971.
2. Fleckenstein A: Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle. Ann Rev Pharmacol Toxicol 17: 149–166, 1977.
3. Fleckenstein A: Steuerung der myocardialen Kontraktilität, ATP-Spaltung, Atmungsintensi- tät und Schrittmacher-Funktion durch Calcium-Ionen — Wirkungsmechanismus der Calcium-Antagonisten. In: Calcium-Antagonismus, Proceed, of an Internat. Symposium 1978 in Frankfürt, (Fleckenstein A, Roskamm H, eds.), pp 1–28, Springer-Verlag, Berlin-Heidelberg-New York, 1980.
4. Fleckenstein A: Fundamental actions of calcium antagonists on myocardial and cardiac pacemaker cell membranes. In: New Perspectives on Calcium Antagonists, Weiss GB (ed), Clin Physiol Series, Amer Physiol Society, 59–81, 1981.
5. Fleckenstein A: History of calcium antagonists. In: Calcium Channel Blocking Drugs: A Novel Intervention for the Treatment of Cardiac Disease. Schwartz A, Taira, N (eds), pp 3–16, Monograph Nr. 95 of the American Heart Association, Circulation Research, Part II, Vol 52, Nr. 2, 1983.